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Abstract
Background. DNA adenine methyltransferase (dam) has been well documented for its role in regulation of replication, mis-
match repair and transposition. Recent studies have also suggested a role for dam in protection against antibiotic stress, 
although this is not yet fully defined. We therefore evaluated the role of dam in the development of antibiotic resistance and 
triclosan- associated cross- resistance.
Results. A significant impact on growth rate was seen in the dam knockout compared to the parental strain. Known triclosan 
resistance- associated mutations in fabI were seen regardless of dam status, with an additional mutation in lrhA seen in the dam 
knockout. The expression of multiple antibiotic resistance- associated genes was significantly different between the parent and 
dam knockout post- resistance induction. Reversion rate assays showed that resistance mechanisms were stable.
Conclusions. dam knockout had a significant effect on growth, but its role in the development of antibiotic resistance is likely 
confined to those antibiotics using acrAD- containing efflux pumps.
DATA SUMMARY
The whole- genome sequencing data of the strains used in this 
study are available from NCBI under the BioProject accession 
number PRJNA517874.
BACKGROUND
In order to maximize survival, clonal bacterial populations 
(cultured from a single colony) exhibit phenotypic cell–cell 
variation. While it has generally been assumed that mutation, 
spread through the population via vertical descent, is the cause 
of such variation, it is becoming increasingly apparent that 
epigenetic changes are also involved [1, 2]. Adenine methyla-
tion is the most common epigenetic change in prokaryotes 
[3], and in Gram- negative bacteria it is primarily mediated 
by DNA adenine methyltransferase (dam) [3, 4]. dam has 
been shown to be involved in mismatch repair [3, 4], regula-
tion of replication [5, 6], transposition [7, 8] and control of 
gene expression [9]. dam has also been linked to antibiotic 
resistance (ABR) – Adam et al. saw increased resistance to 
ampicillin, tetracycline and nalidixic acid in Escherichia coli as 
a result of epigenetically induced changes in the expression of 
resistance- associated genes [2]. Conversely, a role for dam has 
been suggested in protection against antibiotic stress; E. coli 
lacking dam exhibit compromised survival in the presence 
of ampicillin, likely as a result of a build- up of double strand 
breaks [10]. The expression of broad- spectrum resistance- 
associated genes such as the acrAB/D- tolC efflux pumps of 
E. coli have been shown to be regulated by dam [11–13], 
adding support to the potential role for dam in the develop-
ment of ABR. Given that dam homologues are widespread 
amongst bacteria [14], a full understanding of the role of 
adenine methylation in the development of resistance is 
critical for the identification of potential new targets for drug 
development.
Triclosan (TCS) is a broad- spectrum biocide that has 
recently been restricted due to concerns that it may have 
toxic or carcinogenic effects, in addition to concerns about 
antibiotic cross- resistance [15–18], but it is still used in 
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Salmonella enterica serovar Typhimurium, TCS selects for 
increased resistance to ampicillin, tetracycline, ciprofloxacin 
and kanamycin, and also increased expression of the acrAB 
efflux pump [20, 21]. Furthermore, TCS has been seen to 
modulate efflux pump expression directly in Stenotropho-
monas maltophilia, by binding to the repressor smeT, allowing 
expression of the smeDEF efflux pump [22]. While data [23] 
support the involvement of efflux pumps in TCS- mediated 
cross- resistance, the specific mechanisms have yet to be fully 
elucidated. Due to the heavy commercial dependence on TCS, 
the Scientific Committee in Consumer Safety highlights the 
need for further in vitro studies to demonstrate if, when used 
at sub- lethal concentrations, TCS causes the development of 
antibiotic cross- resistance and to determine the mechanisms 
behind this [15]. Our hypothesis is that dam is able to regulate 
efflux pump expression and that this mechanism underpins 
the development of TCS- induced cross- resistance.
METHODS
TCS resistance
The minimum inhibitory concentration (MIC) of the parental 
and dam (ECK3374) knockout (E. coli BW25113 strain and 
isogenic knockout strain, Keio Knock- out Collection, Dhar-
macon) was determined using broth microdilution. Parallel 
dam knockout and parental cultures were serially sub- cultured 
in nutrient broth with increasing TCS concentrations for 7 
consecutive days. TCS was used at 1 µg ml−1 until day 5 and 
10 µg ml−1 between days 5 and 7. The growth rates of initial 
cultures and TCS- resistant mutants, obtained from single 
colonies cultured on nutrient agar (10 µg ml−1 TCS), were 
assessed over 24 h using spectrophotometry and antibiotic 
cross- resistance using disc diffusion (MASTRING- S systemic 
Gram negative M14 multi- disc, MAST, UK). The sensitivity 
of each strain was determined according to the guidelines in 
the BSAC Methods for Antimicrobial Susceptibility Testing 
[24]. Fitness costs were calculated from relative growth rates.
RT-qPCR
RNA was extracted from starting cultures and resistant 
mutants, using the PureLink RNA Mini kit (Thermo Fisher 
Scientific, UK) following the standard protocol. RNA concen-
tration and 260/230 and 260/280 ratios were determined 
through microvolume spectrophotometry (Denovix). RNA 
integrity was assessed via gel electrophoresis. Non- degraded 
samples (260/230~2.2 and 260/280~2.0) were accepted for 
cDNA synthesis using the Verso cDNA Synthesis kit (Thermo 
Scientific) following the standard protocol. RTq- PCR was 
performed with iTaq universal SYBR Green supermix 
(Thermo Fisher, UK) using a CFX96 Touch Real- Time PCR 
Detection System. The primer sequences were as indicated in 
Table 1. Cycling conditions were as follows: 95 °C for 5 min; 
40 cycles of 95 °C for 5 s; 60 °C for 30 s. hcaT was shown to 
be a suitable reference gene by Normfinder, as determined 
experimentally from three genes (hcaT, cysG and rpoS) [25]. 
Fold change was calculated using ΔΔCt and was relative to the 
starting parent strain. Differences in mean fold changes were 
assessed using Welch’s analysis of variance (ANOVA) with a 
significance level 0.05 in SPSS (V.25).
Reversion rate assay and ability to grow at high 
TCS concentrations
Initial strains and TCS- resistant mutants were cultured in 
TCS- free nutrient broth for 24 h at 37 °C. Ability to grow in 
the presence of TCS was assessed by plating 100 μl of the 
overnight culture on nutrient agar/TCS plates (10 µg ml−1). 
Cultures were then propagated in TCS- free media every 24 h 
for 10 days with a sample being plated on nutrient agar/TCS 
plates alongside. The reversion rate was determined as the 
time in days until the loss of TCS resistance. As reversion 
Table 1. RT- qPCR primer sequences
Gene Primer sequence Gene Primer sequence
acrA F GAGTACGATCAGGCTCTGGC CysG F TTGTCGGCGGTGGTGATGTC
R AGGAAGTCGTTGCTGGACTG R ATGCGGTGAACTGTGGAATAAACG
acrB F CAGGATCAACGCCACCAGTA rpoS F TATGAGTCAGAATACGCTG
R AGGAAGTCGTTGCTGGACTG R GGAACAGCGCTTCGATATT
acrR F AAGAAACGCGCCAACACATC HcaT F GGCACTGCTGACACTTCTCT
R CAGCGAGGTGGATGATACCA R TAGTGACCAGTTTGCCCGTC
tolC F CGTTTTTCGGCTTCTTTCAG lrhA F GGCGGTAAGCCATCTACTCC
R TTTTAACGGGCCTGGTAG R CCTCGCCAACACACTGGTACT
marA F CATAGCATTTTGGACTGGAT Fabl F CCGCGTAGAAGAATTTGCCG




Hughes et al., Access Microbiology 2020
was not noted after 10 days, we continued to assay the upper 
limit of resistance. Therefore, at days 10, 15, 20, 25 and 30 TCS 
concentration in the plates was increased to 0.1, 0.15, 0.2, 0.5 
and 1 mg ml−1, respectively.
Genome sequencing
DNA was extracted using a PureLink Genomic DNA Extrac-
tion kit (Invitrogen) with the standard protocol. A micro-
volume spectrophotometer (Denovix) was used to quantify 
the concentration and 260/230 and 260/280 ratios.
Initial cultures and resistant mutants of the parent and dam 
knockout strains were sequenced using Illumina MiSeq 
chemistry and 2×250 bp paired end reads (MicrobesNG, UK). 
Raw reads were processed using the Comprehensive Genome 
Analysis pipeline in PATRIC and variants identified using 
the Variation Analysis service [26]. The BioProject accession 
number for the sequences is PRJNA517874.
RESULTS
Dam loss had a significant effect on the generation 
time of E. coli
Dam has been linked to alterations in the growth of E. coli 
[27] and, given this, we initially sought to confirm these 
findings by assessing the baseline effect of dam on growth 
and in doing so confirm that alterations post- TCS resistance 
were not linked to significant differences pre- induction. Both 
strains were able to grow, confirming the non- essential status 
of dam in E. coli, but the mean generation time for the dam 
knockout was significantly higher compared to the parent 
pre- TCS exposure. The absence of dam was seen to equate to a 
fitness cost of −7.4 % (Table 2). There was an increased genera-
tion time for the parental strain, and this is believed to be 
related to the culture volume (100 µl) and slightly decreased 
aeration from the shaking of the spectrophotometer.
Dam knockout induced resistance to TCS and 
altered global antibiotic resistance patterns
Since methylation of GATC sites by dam mediates survival 
of E. coli in the presence of antibiotics [10], we assessed 
the impact of dam knockout on a range of antibiotics 
(ampicillin, cephalothin, colistin sulphate, gentamicin, 
streptomycin, sulphatriad, tetracycline, cotrimoxazole). 
Prior to the induction of TCS resistance, and with the 
exception of streptomycin (Fig. 1b), the resistance profiles 
of the dam knockout and the parent were not significantly 
different. Within the parental strain, cross- resistance to 
cephalothin developed alongside TCS resistance (Fig. 1a). 
However, within the dam knockout the development of 
TCS resistance led to increased resistance to streptomycin 
and gentamicin (Fig. 1b, c), suggesting that the loss of dam 
may have a role in resistance to aminoglycoside antibiotics. 
In contrast, the increase in resistance to cotrimoxazole 
(Fig. 1e) for both the TCS- resistant parent and the dam 
knockout suggests a non- dam- dependent mechanism of 
cross- resistance. Additionally, the dam knockout was also 
more resistant to TCS, with an MIC of 0.9 μg ml−1 compared 
to 0.4 μg ml−1 for the parent, suggesting a further role for 
dam in resistance to TCS.
The dam knockout showed no difference in the 
mechanism of TCS resistance or in the development 
of resistance-associated mutations
Loss of dam has been associated with an increase in 
mutation rate through the partial induction of the SOS 
regulon and loss of mismatch repair capability, suggesting 
the possibility of increased genomic instability [28]. We 
hypothesized that this increase in mutation rates could 
result in global antibiotic resistance- associated mutations 
within the TCS- resistant dam knockout. In order to assess 
this, we sequenced parental and dam knockout strains pre- 
and post- TCS exposure (Table 3). Sequencing showed that 
there were few mutations, with the most significant being a 
substitution present in the fabI gene, resulting in a change 
at amino acid 93 (glycine to valine). This mutation has been 
widely associated with TCS resistance and confers altered 
binding properties to enoyl- acyl carrier protein reductase 
(ENR) [29].
In the TCS- resistant dam knockout there was an additional 
mutation upstream of fabI as well as upstream of 5 s rRNA, 
and an insertion in lrhA, a transcriptional repressor of the 
lysR family. Within the resistant parent there were no other 
mutations commonly associated with broad- spectrum 
AMR, and TCS resistance was therefore attributed to those 
mutations seen within fabI. For both the TCS- resistant 
parent and the dam knockout, these mutations were seen to 
be highly stable, as neither the parent nor the dam knockout 
TCS- resistant mutants reverted to sensitivity after 30 days 
of growth in the presence of TCS at concentrations up to 
100 times greater than the pre- TCS resistance MIC.
There were significant differences in the 
expression of resistance-associated regulatory 
genes in the dam knockout
Several resistance mechanisms are mediated through 
changes in efflux pump expression, and TCS- associated 
cross- resistance has been suggested to act via efflux pumps 
[23, 30]. In order to assess both these observations, we 
investigated the expression levels of several efflux compo-
nents. We also looked at the expression levels of genes 
Table 2. Mean generation times and fitness costs associated with dam 
loss and TCS resistance
Mean generation t 
ime+/−se min
Fitness cost relative to parent 
start+/−se %




dam knockout start 72.0+/−0.6 −7.4+/−1.1




Hughes et al., Access Microbiology 2020
whose sequences were mutated (Fig. 2). Interestingly, post- 
resistance induction, we found no significant differences 
between the parent and dam knockout in expression of 
acrAB- tolc (Fig. 2a, c and d), or within the multiple- antibiotic 
resistance protein marA (Fig. 2h), or the transcriptional 
regulator acrR (Fig. 2e), suggesting that the action of these 
pathways is not dam- dependent. In contrast, expression 
levels differed for acrD, marR, rpoS, fabI and lrhA (Fig. 2b, 
f, g, i and j), suggesting that dam affects the regulation of 
some efflux pump genes and that TCS- associated antibiotic 
cross- resistance may be more predominant for antibiotics 
whose mechanisms of resistance are related to efflux by the 
acrAD- tolC efflux pump, such as some aminoglycosides 
[31], an observation supported by increased resistance to 
streptomycin and gentamicin in the TCS- resistant dam 
knockout. The elevated expression levels of rpoS seen within 
the dam knockout (Fig. 2g may account for the relatively 
few mutations seen within the start and the TCS- resistant 
dam knockout, as rpoS has a protective role in DNA damage 
due to its ability to upregulate both the SOS response and 
DNA polymerase Pol II.
DISCUSSION
Methylation of the adenine within 5′-GATC-3′ sites of double- 
stranded DNA following replication is a key process within 
DNA mismatch repair [32], alterations in gene expression 
[12] and the initiation of chromosome replication [33] and, as 
such, loss of dam has potentially wide- reaching effects. Here 
we have shown that the loss of dam results in a significantly 
decreased mean generation time and that its absence contrib-
utes to differences in the ABR profile compared to a wild- type 
Fig. 1. Cross- resistance to cephalothin developed alongside TCS resistance in the presence of dam (a), but the loss of dam also contributed 
to increased resistance to streptomycin (b) and gentamicin (c). The TCS- resistant parent was fully cross- resistant to cephalothin (zone of 
0 mm). TCS resistance induced increased resistance to tetracycline in the resistant parent compared to the start parent (d). Decreased 
resistance to cotrimoxazole was observed in the start parent compared to the TCS- resistant parent and the start knockout compared to 
the TCS- resistant knockout (e). Diameters were calculated from three repeats of three lines (three technical repeats of three biological 
repeats, n=9), error bars show standard error, * denotes t- test P<0.05.
5
Hughes et al., Access Microbiology 2020
parental strain and confers a measure of resistance to the 
antimicrobial TCS. The increased generation time (Table 2) 
seen with the dam knockout matches observations of dam- 
deficient strains of uropathogenic E. coli [34]. This increase is 
likely a consequence of the role of dam in replication [32, 34]. 
We also observed a longer lag period in the dam knockout, 
which may be a consequence of the lack of replication initia-
tion coordination. Whilst a clear fitness cost is seen within 
the dam knockout (Table 2), this value is significantly less 
than that for the TCS resistance dam knockout and parent. 
We also did not detect any inherent mutations, expression 
values or antibiotic susceptibilities within the starting dam 
knockout that would indicate that it is inherently unable to 
develop resistance. A comparison of the ABR profiles (Fig. 1) 
between the parent and dam knockout strains prior to resist-
ance induction showed that the dam knockout is marginally 
more resistant to the tested antibiotics than the parent strain, 
although the difference is only significant for streptomycin. We 
attribute this increase in resistance to the observed increased 
expression of rpoS, a general stress response regulator [35], 
which is significantly higher in the starting dam knockout 
(Fig. 2g). A recent study has shown that 100 genes are regu-
lated by rpoS in E. coli, including penicillin- binding proteins 
(PBPs) [36]. rpoS has been associated with antibiotic resist-
ance to β-lactams in E. coli [37] and tolerance to carbapenems 
in Pseudomonas aeruginosa via regulation of PBP expression 
[38], and been demonstrated to have a significant effect in 
single- and double- strand DNA break repair and tolerance 
[39]. rpoS has also been shown to be protective against the 
type of DNA damage caused by aminoglycosides in E. coli 
[40]. This mechanism was not exacerbated by TCS resistance 
within either the parent or DAM knockout (Fig. 1b), demon-
strating that this is not a mechanism of cross- resistance and 
nor is it DAM- dependent here. The increased rpoS expression 
may also explain the low number of mutations seen within the 
TCS- resistant dam knockout, as rpoS has a protective role in 
DNA damage due to its ability to upregulate the ada response 
[37]. Cross- resistance to cephalothin was seen within the 
TCS- resistant parent but not the TCS- resistant knockout, 
suggesting a role for dam. Broadly speaking, β-lactam resist-
ance occurs via one of two mechanisms, either through the 
production of β-lactamase, which is most common in Gram- 
negative species, or via the production of an altered penicillin- 
binding protein [41]. As neither of these pathways would 
derive from TCS resistance, we suggest that cephalothin 
cross- resistance developed from upregulation of marA and 
the concurrent decrease of marR (Fig. 2f, h), whereby upregu-
lation of the resistance- nodulation- cell division (RND) family 
efflux systems (acrAB, acrAD, acrEF, mdtEF and mdtABC) 
results in resistance. Significantly, each of the five listed RND 
family drug exporters have been shown to confer resistance 
to β-lactam antibiotics within E.coli [42]. Whilst significant 
differences in the expression of the acrAB- tolC system were 
not seen, it is possible that mdtEF and mdtABC expression 
levels were elevated.
Cross- resistance to tetracycline was increased in the TCS- 
resistant parent and dam knockout. Within the TCS- resistant 
parent we saw no mutations within the ribosomal- binding 
site, or chromosomal mutations leading to increased expres-
sion of the intrinsic resistance tetracycline tet- on tet- off 
system (Table 3), suggesting that the mechanism of resist-
ance is broad- spectrum efflux by an unobserved mechanism 
such as that highlighted above. Additionally, we observed 
the development of cross- resistance to cotrimoxazole for 
both the TCS- resistant parent and dam knockout. In E. 
coli, cotrimoxazole resistance is primarily via mutations in 
the target sites of the two composite drugs trimethoprim 
Table 3. Variants identified in the starting knockout strain and the TCS- resistant mutants




Nonsyn fabI 278G>T Gly93Val 1 345 019 1
Nonsyn tfaD CAGCGAC>TAACGAT GlySerAsp2GlyAsnAsp 577 016 0.57
Synon tfaD 18C>A Ile6Ile 577 004 0.53
Synon yecE 54G>T Gly18Gly 1 945 705 0.52
Intergenic tfa- nu1 AC >GT – 576 968 0.52
Intergenic tfa- nu1 C>G – 576 974 0.56
Intergenic tfa- nu1 GCGGGCC>ACGCGCG – 576 980 0.6
dam knockout start Intergenic kgtP- 5SrRNA (rrnG operon) T>C – 2 719 426 1
TCS- resistant dam 
knockout
Nonsyn fabI 278G>T Gly93Val 1 345 019 1
Intergenic fabI G>A – 1 345 411 0.51
Synon pcnB 243G>A Val81Val 155 338 0.95
Insertion lrhA 28_29insACCTCG Asn10_Leu11insLeuAsp 2 400 079 0.86
Intergenic kgtP- 5SrRNA (rrnG operon) T>C – 2 719 426 1
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Fig. 2. Expression of the components of the acrAB- tolC efflux pump was not significantly different in the dam knockout compared to the 
parent, but expression was increased in both TCS- resistant strains. There were significant differences between the dam knockout and 
parent pre- resistance induction in rpoS, fabI and marR. In TCS- resistant strains, there were only significant differences in the expression 
of acrD, lrhA, fabI and marR, although there were significant differences between pre- post- induction levels of marA for both the parent 
and dam knockout. Expression was calculated from three repeats of three lines (three technical repeats of three biological repeats, n=9), 
error bars show standard error, * denotes t- test P<0.05.
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[dihydrofolate reductase (dfr)] and sulphonamides [dihy-
dropteroate synthase (folP)] [43, 44]. However, we did not 
detect any point mutations in either of these genes (Table 3). 
Increased expression of E. coli acrAB- tolC and mexAB- oprM 
systems have been shown to confer resistance to sulphona-
mides. Efflux of sulphonamides would inevitably reduce the 
overall effectiveness of cotrimoxazole, as sulphonamides and 
trimethoprim work bactericidally in combination to reduce 
cellular tetrahydrofolic acid levels. As discussed previously, 
expression of the acrAB- tolC genes did not increase post- TCS 
resistance, and resistance may therefore be mediated by an 
alternative efflux system.
An interesting observation from this work is the identifica-
tion of the insertion mutation in lrhA in the dam knockout 
(Table 3). This mutation is also seen in chloramphenicol- 
resistant dam knockouts (Hughes, et al., unpublished data). 
This mutation causes an inframe insertion of leucine and 
aspartic acid. While the effect of the mutation is unknown, 
it is predicted to be deleterious by the Protein Variation 
Effect Analyzer (Provean) [45]. LrhA belongs to the lysR 
family and contains a helix–turn–helix (HTH) DNA- binding 
domain (amino acids 11–68), which overlaps with the inser-
tion mutation (between amino acids 10 and 11). Mutations 
in such domains in other HTH- containing DNA- binding 
proteins have been shown to decrease DNA- binding capa-
bility [46, 47]. If the DNA- binding ability of lrhA is decreased 
as a consequence of this mutation it would no longer be able 
to repress rpoS to the same extent as the wild- type, which 
may contribute to the increased rpoS expression seen here. 
Within the TCS- resistant dam knockout a synonymous muta-
tion was seen in pcnB. While deletion mutations of pcnB have 
been shown to confer resistance to high concentrations of 
chloramphenicol, ampicillin and kanamycin, the significance 
of this mutation, apart from a general contribution to altered 
fitness costs, is unknown [48]
Marginally increased resistance to TCS was seen in the dam 
knockout strain compared to the parental strain prior to 
resistance induction, with MICs of 0.9 μg ml−1 v 0.4 μg ml−1, 
respectively. Post- TCS resistance, TCS- exposed knockouts 
and parent strains were able to grow at concentrations up to 
100 times greater than the initial concentration. TCS acts by 
disrupting the synthesis of fatty acids by competitive inhibi-
tion of ENR. TCS interaction increases the affinity of ENR for 
nicotinamide adenine dinucleotide (NAD+), resulting in the 
development of the stable ternary complex ENR/–NAD/TCS. 
In this form, ENR is unable to synthesize fatty acids [47]. In 
the dam knockout, the level of fabI is significantly increased 
(Fig. 2. I), and this may contribute to a higher tolerance for 
TCS through the increased availability of ENR. There is an 
additional mutation (G>A) upstream of fabI, (Table 3); this 
base is the first site of the fadR- binding site located in the 
fabI promoter [49]. FadR is a transcriptional activator of 
fatty acid synthesis and its loss has been shown to signifi-
cantly decrease fabI expression [50]. While the functional 
effect of this mutation is unknown, it may be that it results 
in increased binding of fadR to the fabI promoter and so 
contributes to the increased expression seen here. Increased 
fabI expression is also seen in the resistant dam knockout and 
parent, with a significantly greater level of expression seen 
in the dam knockout, which may explain the shorter time to 
resistance observed here – 3 and 5 days for the dam knockout 
and parent, respectively. The resistance- associated mutation, 
Gly93Val, was seen in all sequences for both the resistant 
parent and dam knockout. This mutation is associated with 
changes to the protein structure and altered interactions with 
TCS leading to significant increases in resistance [29]. This is 
reflected by the ability of the post- resistance induction strains 
to grow in the presence of a 500- fold greater concentration of 
TCS (450 μg ml−1).
While dam plays an important role in a range of key physi-
ological processes, and loss of its activity confers a measure 
of inherent resistance to TCS, the loss of dam does not appear 
to enhance the development of cross- resistance in most cases, 
either through an increase in the number of mutations or 
in the expression level of efflux associated. These findings 
match the assertion of Cohen et al. [10] that dam provides 
structural support during exposure to antibiotics. This may, 
however, depend on the specific mechanism of the agent 
investigated (e.g. antibiotics whose resistance mechanisms 
rely on non-acrAB- tolC efflux or antibiotics that target DNA 
replication, such as quinolones) [10].
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